USA SHIPPEDFREE SHIPPING ON ORDERS OVER $300≥99% PURITY - HPLC + MASS SPECENDOTOXIN TESTED · STERILITY VERIFIEDCOA CERTIFIED · EVERY BATCH TESTEDRESEARCH USE ONLY
USA SHIPPEDFREE SHIPPING ON ORDERS OVER $300≥99% PURITY - HPLC + MASS SPECENDOTOXIN TESTED · STERILITY VERIFIEDCOA CERTIFIED · EVERY BATCH TESTEDRESEARCH USE ONLY
PT-141 10mg peptide vial
Wellness series

PT-141 10mg

Bremelanotide, a cyclic seven amino acid melanocortin receptor agonist derived from Melanotan II. 99%+ purity, U.S. lab tested.

99%+ PURITYAH-PT141-10In stock
$29.99

Bundle & save

Select a quantity. Savings apply automatically.

Up to 5% off
1
Certificate ships with the vial — lot-matched COA, chromatogram, handling sheet.
Held at −20 °C — pulled once, packed with coolant sized to transit.
Order before 2pm — leaves cold storage the same working day.

PT-141, also known as bremelanotide, is a cyclic heptapeptide and an active metabolite of Melanotan II. Unlike its parent compound it has negligible effect on melanogenesis. Research interest centres on melanocortin receptor signalling, particularly the MC3R and MC4R subtypes.

Specification

Written On The Vial.

Lot-matched certificate ships with every vial
SEQUENCEAc-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH
MOLECULAR FORMULAC50H68N14O10
MOLECULAR WEIGHT1025.2 g/mol
CAS NUMBER189691-06-3
PRESENTATIONLyophilised powder, sealed vial
STORAGE-20 °C sealed · 2-8 °C reconstituted
SOLUBILITYBacteriostatic water
Also in the range

Related Products.

All compounds
Access confirmation

Before you enter.

AminoHaus supplies compounds strictly for in-vitro laboratory research and analytical reference use by qualified professionals.

  • Laboratory research onlyFor in-vitro research and analytical reference use.
  • No human or veterinary useNot for consumption, administration, food, or drug manufacture.
  • No medical purposeNot intended to diagnose, treat, cure, or prevent any condition.

The complete research-use disclaimer remains available in the site footer. Acceptance applies only to this browser session; you'll confirm again next session.

Stay close to the record.

New compound releases and certificate updates—delivered to your inbox.